Monoclonal gammopathies: Electronic subspecialty consultation

Area of Science:

• Healthcare delivery innovation
• Subspecialty care access
• Hematology and oncology informatics

Background:

• Electronic consultation (e-consult) is vital for Veterans Health Administration patients needing subspecialty input without urgent in-person visits.
• Monoclonal Gammopathy of Undetermined Significance (MGUS) is a frequent indication for e-consults, requiring diligent evaluation and long-term surveillance.
• Optimizing e-consult workflows is essential for managing common, yet potentially progressive, hematologic conditions.

Purpose of the Study:

• To assess the effectiveness of e-consults in managing Monoclonal Gammopathy of Undetermined Significance (MGUS).
• To identify specific areas for improvement in MGUS care delivery via the e-consult platform.
• To evaluate the efficiency and outcomes of e-consults for MGUS patients within a large healthcare system.

Main Methods:

• Retrospective analysis of 152 MGUS patients undergoing e-consultation between 2010 and 2014.
• Review of e-consult database to assess patient characteristics and care processes.
• Longitudinal follow-up to track disease progression and surveillance patterns.

Main Results:

• Median e-consult completion time was 2 days, indicating rapid evaluation.
• Most MGUS patients in the e-consult cohort presented with low-risk laboratory values (Hemoglobin >10 g/dL, Creatinine <2 mg/dL).
• Paraprotein surveillance intensity fluctuated over time; 6 progression events occurred over a median 44-month follow-up (1% annual progression rate).

Conclusions:

• E-consultation serves as an efficient tool for evaluating MGUS, successfully decreasing the need for traditional outpatient appointments.
• Effective MGUS management via e-consult necessitates robust, timely risk stratification protocols.
• Sustained and consistent patient surveillance following e-consultation is paramount for detecting progression and ensuring optimal outcomes.